Jenthera Therapeutics Inc. is an active federal corporation (corporation number 11342649). Its business number is 701783482. It was incorporated on Apr 5, 2019 under the Canada Business Corporations Act and its registered office is in Cote St-Luc, Quebec. Its annual returns are up to date, most recently for 2026. It has three directors on record.
Corporate details
- Corporation number
- 11342649
- Business number
- 701783482
- Status
- Active
- Governing law
- Canada Business Corporations Act
- Incorporated
- Apr 5, 2019
- Corporation type
- Non-distributing corporation with 50 or fewer shareholdersAs declared in its 2026 annual return.
- Registered office
- 5673 Midway Av.
Côte St-Luc QC H4W 1K7 - Number of directors
- At least 1, at most 10As the articles allow.
Annual filings
- Anniversary date
- Apr 5The date of incorporation, amalgamation or continuance.
- Annual filing period
- Apr 5 to Jun 4 each year
- Last annual meeting
- Apr 10, 2026
| Year | Annual return | Annual meeting |
|---|---|---|
| 2026 | Filed | Apr 10, 2026 |
| 2025 | Filed | Jan 31, 2025 |
| 2024 | Filed | Apr 5, 2024 |
The last annual return filed, and each year since.
Directors
Loading the directors from the federal record...
Federal grants and contributions
7 agreements since 2020, worth $780,263 in all.
| Department | Program | Value | Starts |
|---|---|---|---|
| National Research Council Canada | MNC Collab – 34 - SC: In vivo Editing Strategy for Treatment of Sickle Cell Anemia | $500,000 | Jan 5, 2026 |
| National Research Council Canada | ARP - MNC Collab - Immuno-Nuc-Nab - Development and Validation of CRISPR RNP delivery to Immune Cell populations | $75,000 | Oct 1, 2024 |
| National Research Council Canada | Jenthera Therapeutics Inc.-2023-2024-1012164 | $22,312 | Jun 18, 2023 |
| National Research Council Canada | In vivo proof of concept study of Nuc-Nab gene editing complex targeting the KRAS oncogene | $98,270 | Dec 20, 2021 |
| National Research Council Canada | Innovation Assistance Program – Round 2.5 | $13,385 | Dec 20, 2020 |
| National Research Council Canada | Innovation Assistance Program – Round 2 | $35,632 | Jun 25, 2020 |
| National Research Council Canada | Innovation Assistance Program | $35,664 | Apr 1, 2020 |
As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. Search every federal grant.
Names
| Name | Form | In use since |
|---|---|---|
| Jenthera Therapeutics Inc. | Name | Apr 5, 2019 |
Filings and certificates
| What | Date |
|---|---|
| Incorporated | Apr 5, 2019 |
Registered in a province as well? Find provincial registrations(opens in a new tab). Something wrong or out of date? Request a correction.